11 companies

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$7.2b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

3613

HK$8.46

7D

-1.9%

1Y

-1.9%

Tong Ren Tang Technologies

Market Cap: HK$5.4b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

1666

HK$4.14

7D

-1.9%

1Y

-19.8%

Consun Pharmaceutical Group

Market Cap: HK$14.6b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$16.38

7D

-4.5%

1Y

82.2%

Shandong Xinhua Pharmaceutical

Market Cap: HK$10.1b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

719

HK$6.86

7D

1.5%

1Y

17.1%

Essex Bio-Technology

Market Cap: HK$2.2b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$3.70

7D

-6.6%

1Y

28.0%

CSPC Pharmaceutical Group

Market Cap: HK$105.1b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$9.02

7D

4.3%

1Y

74.1%

China Shineway Pharmaceutical Group

Market Cap: HK$6.9b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

2877

HK$9.05

7D

-2.8%

1Y

0.6%

Shanghai Haohai Biological Technology

Market Cap: HK$10.0b

Shanghai Haohai Biological Technology Co., Ltd.

6826

HK$23.62

7D

-2.9%

1Y

-15.8%

Jacobson Pharma

Market Cap: HK$2.5b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.24

7D

-0.8%

1Y

6.9%

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.7b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

2348

HK$1.15

7D

0%

1Y

-4.2%

Pak Fah Yeow International

Market Cap: HK$744.8m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

239

HK$2.39

7D

3.0%

1Y

10.6%